217 related articles for article (PubMed ID: 25387323)
1. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.
Masi G; Milone A; Viglione V; Mancini A; Pisano S
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):536-42. PubMed ID: 25387323
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics and rhabdomyolysis. Differential diagnosis and clinical significance of elevated serum creatine kinase levels in psychiatric practice].
Vörös V; Osváth P; Fekete S; Tényi T
Psychiatr Hung; 2009; 24(3):175-84. PubMed ID: 19794225
[TBL] [Abstract][Full Text] [Related]
3. All elevated creatine kinase is not neuroleptic malignant syndrome.
Maniam T; Rahman MA
Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
[TBL] [Abstract][Full Text] [Related]
5. Marked elevation of serum creatine kinase associated with olanzapine therapy.
Marcus EL; Vass A; Zislin J
Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
[TBL] [Abstract][Full Text] [Related]
6. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
[TBL] [Abstract][Full Text] [Related]
8. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
Peschel O; Kurtz G; Müller-Felber W; Modell S
Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride and neuroleptic malignant syndrome.
Tu MC; Hsiao CC
Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
[TBL] [Abstract][Full Text] [Related]
11. [Olanzapine induced rhabdomyolysis and serum creatine kinase increase].
Ribeyron S; Guy C; Koenig M; Cathébras P
Rev Med Interne; 2009 Jun; 30(6):477-85. PubMed ID: 19307047
[TBL] [Abstract][Full Text] [Related]
12. Massive creatine kinase elevations with quetiapine: report of two cases.
Klein JP; Fiedler U; Appel H; Quante A; Jockers-Scherübl MC
Pharmacopsychiatry; 2006 Jan; 39(1):39-40. PubMed ID: 16453254
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
Sewell DD; Jeste DV
J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
[TBL] [Abstract][Full Text] [Related]
14. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
15. The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome.
O'Dwyer AM; Sheppard NP
Psychol Med; 1993 May; 23(2):323-6. PubMed ID: 8101383
[TBL] [Abstract][Full Text] [Related]
16. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
18. The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.
Adityanjee
Br J Psychiatry; 1991 May; 158():706-7. PubMed ID: 1677602
[No Abstract] [Full Text] [Related]
19. Antipsychotic-Induced Neuroleptic Malignant Syndrome After Cardiac Surgery.
Moll V; Ward CT; Zivot JB
A A Case Rep; 2016 Jul; 7(1):5-8. PubMed ID: 27191714
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.
Chang CK; Payus AO; Noh MM; Lansing MG; Sumpat D; Lu SJA; Yew BT
J Med Case Rep; 2022 Oct; 16(1):366. PubMed ID: 36203196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
